Merrill Lynch Downgrades AptarGroup (ATR) to Neutral
More News related to ATR
- Matrix Upgrades and Downgrades for November 25, 2008
- Notable Analyst Rating Changes 11/20: DSX, BIDU, ATR Upgraded; EGLE, SOL, AMED, PAY Downgraded
- Merrill Lynch Upgrades AptarGroup (ATR) to Buy
- AptarGroup (ATR) Reports In-Line Q3 EPS of $0.57; Guides Q4 Below the Street; Declares Qtr. Dividend of $0.15/Share
- AptarGroup Reports Record Results Driven by Strong Pharma Business; Declares Dividend
More News related to Downgrades
- Post Properties (PPS) Announces Reduction In Quarterly Dividend To 20c, CIO Departure and New Stock Buyback Of Up To $200M
- Roberts Realty Investors (RPI) Increases Stock Repurchase Program
- United American Healthcare (UAHC) Approves $1 Million Stock Buyback
- Quidel Corporation (QDEL) Extends Current Stock Buyback Plan
- Quidel (QDEL) Adds $25M to Buyback Program
Merrill Lynch downgrades AptarGroup (NYSE: ATR) from Buy to Neutral.
AptarGroup, Inc. (AptarGroup) is a supplier of a range of dispensing systems for the personal care, fragrance/cosmetic, pharmaceutical, household and food/beverage markets.
Related Categories
DowngradesStocks Mentioned
+1.19Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
